Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,690,516 papers from all fields of science
Search
Sign In
Create Free Account
MAGEA12 gene
Known as:
MAGE family member A12
, MAGEA12
, MELANOMA ANTIGEN, FAMILY A, 12
Expand
This gene may be involved in carcinogenesis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Immune response
MAGEA12 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma
guohua zhao
,
J. Y. Bae
,
+4 authors
Zhehu Jin
Anticancer Research
2019
Corpus ID: 96448971
Background/Aim: Melanoma-associated antigen A12 (MAGEA12) has recently been reported as a repressor of tumor-suppressor genes…
Expand
2016
2016
Identification of MAGEA12 as a prognostic outlier gene in gastric cancers.
J. Wu
,
J. Wang
,
W. Shen
Neoplasma (Bratislava)
2016
Corpus ID: 34644583
Melanoma antigen (MAGE) family genes are frequently over-expressed in a subset population of multiple cancers, and serve as idea…
Expand
Review
2014
Review
2014
MAGEA3 (melanoma antigen family A, 3)
Biswajit Das
,
S. Suklabaidya
,
Sumeet Jain
,
Baisakh
,
S. Senapati
2014
Corpus ID: 84038607
In the year 1991 Van der Bruggen P et al. cloned and named MAGE-1 gene that encodes MZ2E antigen, which is expressed in melanoma…
Expand
2011
2011
ALK-Negative Anaplastic Large Cell Lymphomas with 6p25.3 Translocations Show a Histone-Modifying Gene Expression Signature
A. Feldman
,
Gaofeng Huang
,
+4 authors
W. Chng
2011
Corpus ID: 208435146
Abstract 88 Introduction: The biology and genetics of anaplastic large T-cell lymphomas (ALCLs) lacking ALK translocations remain…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required